Indiana University School of Medicine researcher Jeff Dage’s years of research into biomarkers helped lead to a ...

The Food and Drug Administration’s (FDA) approval of the first blood test to aid in the diagnosis of Alzheimer’s disease ...

The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, making the test the first to get signoff to aid in the early detection of the ...

In a Friday press release, the agency announced its approval of the first in-vitro diagnostic device, Lumipulse. The method is intended for early Alzheimer’s detection in adult patients over the ...

A simple blood draw has now become a powerful tool in the early fight against Alzheimer’s. The FDA has approved the first blood test to help detect signs of ...

The FDA recently cleared the Lumipulse blood test for early diagnosis of Alzheimer's disease in ... More people 55 and over with memory loss. The noninvasive Lumipulse blood test measures the leve ...

The Lumipulse blood plasma test detects a disease hallmark, amyloid plaques, which form in the brains of Alzheimer's patients. This approval marks a milestone for patients, their families and ...

Its mouthful of a name — Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio — describes what the test measures: levels of two proteins, amyloid and tau, that are hallmarks of Alzheimer’s disease.

WASHINGTON DC - JUNE 20, 2023 Jay Reinstein, right, who suffers from Alzheimer’s, places his hand on his father Max Reinstein’s back prior to to receiving a PET scan at MedStar Georgetown ...

Fujirebio's test works with the company's Lumipulse equipment, which the company says is already "widely available in clinical laboratories" around the U.S. Fujirebio describes Lumipulse as a ...

The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is approved for the early detection of amyloid plaques associated with Alzheimer disease in patients aged 55 years and older who are showing ...

In clinical trials, the Lumipulse blood test was highly accurate at detecting brain plaques tied to Alzheimer’s disease, which paved the way for FDA approval. Compared to brain scans and spinal ...